Corneal specialists Thomas Steinemann, MD, of MetroHealth Medical Center and Ann P. Murchison, MD, MPH, of the Wills Eye Hospital, share tales of Halloween costume contact lens horrors bound to keep ophthalmologists up at night.
Sustained-release dexamethasone intracanalicular insert provided effective inflammation prevention, compared with standard steroid therapy.
A study shows the program could save health systems up to $29 per patient every year.
A single-session, nurse-led clinic staff education program on medication adherence leads to increased knowledge and practice changes at a FQHC.
The burden of depressive symptoms in the US adult population has increased during the course of the COVID-19 pandemic.
The risk for breakthrough COVID-19 infections is increased for fully vaccinated patients with substance use disorders (SUDs).
Health care workers experienced higher levels of stress than other occupations in the first wave of the COVID-19 pandemic.
Even without a MIGS device, surgery-naive patients who underwent phaco-ECP can experience an IOP drop of 26%, a report suggests.
The virus also induces an antiviral innate immune response, a study shows.
In this fifth update to the living guidelines on drugs for the treatment of COVID-19, the World Health Organization analyzed results of clinical trials that assessed the effects of casirivimab-imdevimab and corticosteroids in patients with severe and non-severe disease.
Please login or register first to view this content.
